Canakinumab for Residual Inflammatory Risk

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.

BACKGROUND Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. METHODS We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with pre...

متن کامل

Getting inflamed about canakinumab for CVD

canakinumab for CVD In the good old days, human beings went around in a state of semipermanent inflammation from parasites and infections, ate when they could, starved when they couldn’t, and rarely sat down. Few lived long enough to develop atherosclerosis. But in sedentary, well fed modern people who live beyond 60, inflammation has come to be feared as a cardiovascular risk factor. In a much...

متن کامل

Canakinumab investigated for treating familial Mediterranean fever.

INTRODUCTION Familial Mediterranean fever (FMF) is the most common hereditary autoinflammatory syndrome. The treatment of choice is colchicine. However, ~40% of patients are only partial responders and 5-10% are non-responders. Advances in the understanding of the role of pyrin in the regulation of interleukin (IL)-1β activation has led to use of anti-IL-1 agents for colchicine-resistant FMF. ...

متن کامل

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome

OBJECTIVE To explore whether gene expression profiling can identify a molecular mechanism for the clinical benefit of canakinumab treatment in patents with tumour necrosis factor receptor-associated periodic syndrome (TRAPS). METHODS Blood samples were collected from 20 patients with active TRAPS who received canakinumab 150 mg every 4 weeks for 4 months in an open-label proof-of-concept phas...

متن کامل

is inflammatory pulpal pain a risk factor for amnesia?

the aim of this study was to investigate the effect of inflammatory pulpal pain on spatial learning and memory in male wistar rats. fifty-six adult rats were divided into eight groups as follows (n=7 per group): control, sham-operated group that received normal saline, sham vehicle group that received vehicle of capsaicin, three capsaicin treated groups that received intradental injection of 10...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal

سال: 2017

ISSN: 0195-668X,1522-9645

DOI: 10.1093/eurheartj/ehx723